Cargando…
Assessment of Bleeding Risk in Hospitalized COVID-19 Patients: A Tertiary Hospital Experience during the Pandemic in a Predominant Minority Population—Bleeding Risk Factors in COVID-19 Patients
Introduction: In the wake of the SARS-CoV-2 (COVID-19) pandemic, our world has faced multiple challenges. Infection with this virus has commonly been associated with thrombotic events. However, little is known about bleeding risk and anticoagulation therapy. This study aims to determine factors that...
Autores principales: | Abowali, Hesham, Pacifico, Antoinette, Erdinc, Burak, Elkholy, Karim, Burkhanova, Umida, Aroriode, Tarilate, Watson, Althea, Ahmed, Muhammad Faizan, Uwagbale, Ese, Visweshwar, Nathan, Jaglal, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145335/ https://www.ncbi.nlm.nih.gov/pubmed/35628881 http://dx.doi.org/10.3390/jcm11102754 |
Ejemplares similares
-
Chronic Eosinophilic Pneumonia Masquerading as a Lung Mass
por: Amoda, Oluyemisi, et al.
Publicado: (2022) -
Ivermectin: A Closer Look at a Potential Remedy
por: Elkholy, Karim O, et al.
Publicado: (2020) -
Empiric Anticoagulation Therapy in Hospitalized COVID-19 Patients: An Evaluation of Bleeding Risk Scores Performances in Predicting Bleeding Events
por: Abdelrahman, Mona A., et al.
Publicado: (2022) -
Anticoagulation and bleeding risk in patients with COVID-19
por: Musoke, Nancy, et al.
Publicado: (2020) -
Observed risk of recurrent bleeding and thromboembolic disease in COVID-19 patients with gastrointestinal bleeding
por: Attah, Emmanuel, et al.
Publicado: (2021)